ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.515
+0.155 (11.40%)
At close: Oct 27, 2026, 4:00 PM EDT
1.510
-0.005 (-0.33%)
After-hours: Oct 27, 2026, 4:31 PM EDT
ProKidney Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, ProKidney stock has a consensus rating of "Buy" and an average price target of $6.90. The average 1-year stock price forecast is 355.45% higher than the current stock price, while the lowest is $1.00 (-33.99%) and the highest is $12 (+692.08%).
Price Target: $6.90 (+355.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ProKidney stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Maintains $1 | Sell | Maintains | $1 | -33.99% | Oct 12, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $3 | Hold | Maintains | $3 | +98.02% | Aug 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Maintains $7 | Buy | Maintains | $7 | +362.05% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $12 | Buy | Maintains | $12 | +692.08% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
529.00K
from 893.00K
Decreased by -40.76%
Revenue Next Year
494.20K
from 529.00K
Decreased by -6.58%
EPS This Year
-0.58
from -0.52
EPS Next Year
-0.61
from -0.58
EPS and Forward PE are based on non-GAAP adjusted numbers.